Shares of Amedica Corp (NASDAQ: AMDA),engaged in using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices, registered over a 10.0% gain during each of the past two consecutive trading sessions with significant number of shares exchanging hands. AMDA was the top performer in the U.S. healthcare sector after climbing 39.0% and closed at $2.60 Friday, while recording significant trading volumes of 504,864 shares. AMDA broke its key technical resistance level of 50-Day DMA at $2.06. Recently, the company made an announcement that it would release its Q3’14 financial results on Thursday, November 6, 2014, at approximately 9:00 a.m. Eastern Time. During the past 5-trading sessions, AMDA gained 109.7% with daily average trading volumes of 154,273 shares, while the stock accumulated 51.2% gain during the past one month with daily average trading volumes of 70,070 shares.
Company Description:
Amedica Corporation (NASDAQ: AMDA) designs, manufactures and distributes a broad range of spine and joint implants. The company’s products include a family of spinal implants, which are used to restore and maintain the alignment of vertebrae in the cervical and lumbar region of the spine.
1-Year Stock Chart:
Source: Bloomberg
